510(k) · Cleared
ClearedYumizen H2500
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Horiba Abx Sas · GKZ Counter, Differential Cell
Cleared on May 21, 2024 as substantially equivalent to K112605 (Sysmex America, Inc., 2012) after a 244-day review. Its family tree reaches back 3 generations to 2004. 1 later device descends from it.
- Decided
- May 21, 2024
- Review
- 244 days
- Class
- Class II
- Product code
- GKZ
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K040073 (2004). 1 later device descends from it, 1 citing it directly.
- Root · 3 generations backK040073 Sysmex Automated Hematology Analyzer, XE-2100 Series (XE-2100…Sysmex America, Inc. · 2004
- 2 generations backK071967 Sysmex XE-5000Sysmex America, Inc. · 2007 · Recalled
- 1 generation backK112605 Sysmex XN-SeriesSysmex America, Inc. · 2012 · Recalled
- This deviceK232946 Yumizen H2500Horiba Abx Sas · 2024
- Descendant · cites it directly · 0 of its ownK260781 Yumizen H550Horiba Abx Sas · 2026
Most influential descendants
Showing 1 of 1 · See all- K260781Yumizen H550Horiba Abx Sas · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K040073 | Sysmex Automated Hematology Analyzer, XE-2100 Series (XE-2100, XE-2100L) | Sysmex America, Inc. | 2004 | — |
| −2 | K071967 | Sysmex XE-5000 | Sysmex America, Inc. | 2007 | 1 |
| −1 | K112605 | Sysmex XN-Series | Sysmex America, Inc. | 2012 | 2 |
| 0 (this device) | K232946 | Yumizen H2500 | Horiba Abx Sas | 2024 | — |
| +1 | K260781 | Yumizen H550 | Horiba Abx Sas | 2026 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GKZ device
- #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K112605 | Sysmex XN-SeriesSummary page 13…V. Substantial Equivalence Information A. Predicate Device Name(s) Sysmex XN-series B. Predicate 510(k) Number(s) K112605 C. Comparison with Predicate Table 2 - Comparison with predicate Device & Predicate… | 2012 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K260781 | Yumizen H550 | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 4.9 years on median.
- 2 of the 3 ancestors have a recall of any class.
- Of its descendants, K260781 (Horiba Abx Sas, 2026) has gone furthest, with 0 descendants of its own.
- 12 other devices also cite its predicate K112605.
How does its category compare?
All GKZ devicesGKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.
FDA decisions per year · GKZ
4in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GKZ
108in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GKZ
1in 2025
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · GKZ
77in 2025
MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 117 | 37 | 268 |
| 2008 | 6 | 99 | 5 | 925 |
| 2009 | 6 | 147 | 13 | 559 |
| 2010 | 4 | 290 | 27 | 896 |
| 2011 | 3 | 315 | 28 | 2,905 |
| 2012 | 3 | 408 | 7 | 2,959 |
| 2013 | 1 | — | 6 | 3,070 |
| 2014 | 3 | 165 | 0 | 3,112 |
| 2015 | 3 | 273 | 3 | 1,972 |
| 2016 | 3 | 198 | 3 | 3,338 |
| 2017 | 4 | 280 | 3 | 229 |
| 2018 | 3 | 270 | 2 (2) | 497 |
| 2019 | 5 | 210 | 2 | 908 |
| 2020 | 1 | — | 1 | 342 |
| 2021 | 0 | — | 0 | 391 |
| 2022 | 3 | 638 | 4 | 198 |
| 2023 | 4 | 329 | 1 | 155 |
| 2024 | 3 | 157 | 0 | 115 |
| 2025 | 4 | 108 | 1 | 77 |
| 2026 | 4 | 254 | 0 | — |
What is it indicated for?
The Yumizen H2500 is a quantitative multiparameter fully automated hematology analyzer intended for in-vitro diagnostic use in clinical laboratories by qualified healthcare professionals for the screening of patient populations. The Yumizen H2500 is intended to perform tests on the following specimens: Anticoagulated whole blood specimens Body fluids (synovial fluids, serous fluids and cerebrospinal fluids). The Yumizen H2500 classifies and enumerates…
Read the full statement (202 words)
The Yumizen H2500 is a quantitative multiparameter fully automated hematology analyzer intended for in-vitro diagnostic use in clinical laboratories by qualified healthcare professionals for the screening of patient populations.
The Yumizen H2500 is intended to perform tests on the following specimens:
Anticoagulated whole blood specimens
Body fluids (synovial fluids, serous fluids and cerebrospinal fluids).
The Yumizen H2500 classifies and enumerates the following parameters:
A complete blood count (CBC) consisting of TNC, WBC, RBC, HGB, calculated HCT, MCV, calculated MCH, calculated MCHC, RDW-SD, RDW-CV, PLT, PLT-Ox, LPF, MPV.
A leukocyte differential count consisting of LYM (%/#), MON (%/#), NEU (%/#), EOS (%/#), BAS (%/#), IMG (%/#)
A nucleated red blood cell count consisting of NRBC (%/#).
A reticulocyte analysis consisting of RET (%/#), calculated CRC, IRF, RHCC.
Quantitative determination of blood cells in synovial fluids, serous fluids and cerebrospinal fluids consisting of BFWBC, BFRBC, BFPN (%/#), BFMN (%/#).
Note: Venous and capillary whole blood should be collected in K2EDTA anticoagulant. Serous and synovial fluids should be collected without anticoagulant or in K2EDTA anticoagulant to prevent clotting of fluid. The use of anticoagulants with cerebrospinal fluid specimens is neither required nor recommended. Alternatively, Sodium Heparin or Lithium Heparin may be used for synovial fluid.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K232946 · printed Nov 5, 2026
Cite this page
510(k) Report. “K232946: Yumizen H2500.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K232946
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026